MEG3/MIR-376B-3P/HMGA2轴参与垂体瘤侵袭性
研究分析30例临床无功能垂体腺瘤(CNFPA)患者中MEG3与MIR-376B-3P表达降低与肿瘤侵袭性的关联,并在垂体来源滤泡星形(PDFS)细胞系中进行功能实验,揭示MEG3作为MIR-376B-3P表达增强子、HMGA2作为其靶基因被负调控的调控网络。
要点
- CNFPA患者中MEG3与MIR-376B-3P表达降低,其转录水平与侵袭性CNFPA高度相关。
- PDFS细胞中过表达MEG3与MIR-376B-3P抑制肿瘤发生并促进凋亡。
- MEG3通过富集MIR-376B-3P负调控靶基因HMGA2,HMGA2在垂体腺瘤中起 oncogene 作用。
核心结论
- 本研究提出CNFPA中MEG3/MIR-376B-3P/HMGA2调控网络的新机制,可能成为抗癌治疗的突破点。
研究设计与样本
- 采用定量实时聚合酶链反应分析30例临床无功能垂体腺瘤(CNFPA)患者中MEG3与MIR-376B-3P表达降低是否与侵袭性相关。
- 在垂体来源滤泡星形(PDFS)细胞系中进行功能实验以揭示MEG3、MIR-376B-3P与HMGA2的病理生理作用。
- 应用双荧光素酶报告基因 assay、Western blot分析与免疫荧光揭示MEG3、MIR-376B-3P与HMGA2之间的相关性。
主要发现
- CNFPA患者中MEG3与MIR-376B-3P降低,其转录水平与侵袭性CNFPA高度相关。
- PDFS细胞中过表达MEG3与MIR-376B-3P抑制肿瘤发生并促进凋亡。
- MEG3作为MIR-376B-3P表达的增强子发挥作用。
- HMGA2作为MIR-376B-3P的靶基因,在垂体腺瘤中作为 oncogene 发挥作用,并可被MEG3通过富集MIR-376B-3P负调控。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To date, long noncoding RNAs (lncRNAs) have proven to function as key regulators in tumorigenesis. Among these lncRNAs, MEG3 displays low levels in various neoplasms and tumor cell lines. However, the regulatory mechanism of MEG3 and MIR-376B-3P, one of the microRNAs from downstream gene clusters of the DLK1-MEG3 locus, remains insufficiently defined. METHODS: The authors used quantitative real-time polymerase chain reaction analysis to analyze whether decreased MEG3 and MIR-376B-3P expression levels were associated with the invasiveness of clinical nonfunctioning pituitary adenomas (CNFPAs) in 30 patients. Furthermore, functional experiments unveiled the pathophysiological role of MEG3, MIR-376B-3P, and HMGA2 in pituitary-derived folliculostellate (PDFS) cell lines. Moreover, dual-luciferase reporter assay, Western blot analysis, and immunofluorescence were applied to reveal the correlations among MEG3, MIR-376B-3P, and HMGA2. RESULTS: MEG3 and MIR-376B-3P were decreased in patients with CNFPA, and their transcriptional levels were highly associated with invasive CNFPAs. Moreover, excessive expression of MEG3 and MIR-376B-3P inhibited tumorigenesis and promoted apoptosis in PDFS cells. Importantly, the authors found that MEG3 acted as an enhancer of MIR-376B-3P expression. Furthermore, as a target gene of MIR-376B-3P, HMGA2 served as an oncogene in pituitary adenoma and could be negatively regulated by MEG3 via enriching MIR-376B-3P. CONCLUSIONS: This study offers a novel mechanism of an MEG3/MIR-376B-3P/HMGA2 regulatory network in CNFPAs, which may become a breakthrough for anticancer treatments.
引用
- Zhu D, Xiao Z, Wang Z, et al. MEG3/MIR-376B-3P/HMGA2 axis is involved in pituitary tumor invasiveness. J Neurosurg. 2020. PMID: 31899875. doi:10.3171/2019.10.JNS191959
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。